Does early life adversity affect mental health and social cognition via an inflammatory response

M. Dauvermann , J. Holland , G. Donohoe , D. Morris
The European health psychologist 19 765

2017
Resting-state connectivity deficits associated with impaired inhibitory control in non-treatment-seeking adolescents with psychotic symptoms.

S. C. Jacobson McEwen , C. G. Connolly , A. M. C. Kelly , I. Kelleher
Acta Psychiatrica Scandinavica 129 ( 2) 134 -142

20
2014
Mood congruent psychotic symptoms and specific cognitive deficits in carriers of the novel schizophrenia risk variant at MIR-137

Elizabeth Cummings , Gary Donohoe , April Hargreaves , Susan Moore
Neuroscience Letters 532 ( 1) 33 -38

55
2013
Cortisol stress response in psychosis from the high-risk to the chronic stage: a systematic review.

M. R. Dauvermann , G. Donohoe
Irish Journal of Psychological Medicine 36 ( 4) 305 -315

4
2019
Follow up of schizophrenia gwas based on cognitive performance, high density eeg, and structural brain imaging

Gary Donohoe , E Rose , Derek Morris , April Hargreaves
European Psychiatry 26 ( S2) 2083 -2083

1
2011
Predictors of adherence to low support, computerised, cognitive remediation training in psychosis

April Hargreaves , Rachael Dillon , Marco Castorina , Emilia Furey
Psychosis 10 ( 4) 298 -306

4
2018
Evidence for association and epistasis at the DAOA/G30 and D-amino acid oxidase loci in an Irish schizophrenia sample.

A Corvin , KA McGhee , K Murphy , G Donohoe
American Journal of Medical Genetics 144 ( 7) 949 -953

57
2007
Neuropsychological effects of the CSMD1 genome-wide associated schizophrenia risk variant rs10503253

Gary Donohoe , J Walters , April Hargreaves , Emma Jane Rose
Genes, Brain and Behavior 12 ( 2) 203 -209

37
2013
Predictors of compliance with neuroleptic medication among inpatients with schizophrenia: a discriminant function analysis.

G. Donohoe , N. Owens , C. O’Donnell , T. Burke
European Psychiatry 16 ( 5) 293 -298

100
2001
Neurocognitive phenomics: examining the genetic basis of cognitive abilities

G. Donohoe , I. J. Deary , D. C. Glahn , A. K. Malhotra
Psychological Medicine 43 ( 10) 2027 -2036

10
2013
Neural effects of social environmental stress – an activation likelihood estimation meta-analysis

O. Mothersill , G. Donohoe
Psychological Medicine 46 ( 10) 2015 -2023

30
2016
Anticholinergic burden in schizophrenia and ability to benefit from psychosocial treatment programmes: a 3-year prospective cohort study.

K. O'Reilly , P. O'Connell , G. Donohoe , C. Coyle
Psychological Medicine 46 ( 15) 3199 -3211

16
2016
Genetically predicted complement component 4A expression: effects on memory function and middle temporal lobe activation

Gary Donohoe , Jessica Holland , David Mothersill , Simon McCarthy-Jones
Psychological Medicine 48 ( 10) 1608 -1615

15
2018
Prefrontal cortical thinning links to negative symptoms in schizophrenia via the ENIGMA consortium

Esther Walton , Derrek P Hibar , Theo GM Van Erp , Steven G Potkin
Psychological Medicine 48 ( 1) 82 -94

114
2018
Predictores del cumplimiento de la medicación neuroléptica entre pacientes internos con esquizofrenia: un análisis de la función discriminante

G. Donohoe , N. Owens , N. O’Donnell , T. Burke
European psychiatry (Ed. Española) 9 ( 1) 21 -27

2002
The Psychosis Susceptibility Gene ZNF804A: Associations, Functions, and Phenotypes

Gary Donohoe , Derek W Morris , Aiden Corvin ,
Schizophrenia Bulletin 36 ( 5) 904 -909

50
2010
Clinical symptomatology and the psychosis risk gene ZNF804A

E Cummings , G Donohoe , C McDonald , TG Dinan
Schizophrenia Research 122 ( 1) 273 -275

16
2010
Preserved cognitive function is associated with suicidal ideation and single suicide attempts in schizophrenia

C Delaney , J McGrane , E Cummings , DW Morris
Schizophrenia Research 140 ( 1) 232 -236

53
2012